Balaji Amines Ltd (BALAMINES)
🎯 Key Takeaways
- Revenue grew 15.5% QoQ to ₹456 in Q1FY27.
- Market Cap
- ₹6,860
- P/E Ratio
- 33.5
- P/B Ratio
- 3.47
- ROE
- 10.3%
- ROCE
- 14.0%
- Debt/Equity
- 0.07
- Div Yield
- 0.52%
- Promoter
- 54.6%
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 341 | 331 | 395 | 456 |
| Operating Profit | 46 | 43 | 80 | 102 |
| OPM % | 13.4% | 12.8% | 20.3% | 22.4% |
| Net Profit | 37 | 31 | 65 | 78 |
| EPS | ₹10.67 | ₹9.49 | ₹19.99 | ₹23.13 |
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 6 |
| Reserves | 1,839 | 1,764 | 1,970 | 1,875 |
| Borrowings | 11 | 15 | 133 | 31 |
| Total Liabilities | 2,252 | 2,153 | 2,743 | 2,331 |
| Fixed Assets | 1,003 | 887 | 1,038 | 1,055 |
| Investments | 0 | 0 | 5 | 0 |
| Total Assets | 2,252 | 2,153 | 2,743 | 2,331 |
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2026 |
|---|---|
| Operating | +184 |
| Investing | -344 |
| Financing | +85 |
| Net Cash Flow | -75 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 54.6% | 54.6% | 54.6% | 54.6% |
| FII | 4.5% | 3.3% | 3.0% | 3.2% |
| DII | 1.5% | 1.5% | 1.5% | 1.6% |
| Public | 34.4% | 35.5% | 35.7% | 35.1% |
| # Shareholders | 1,18,894 | 1,17,591 | 1,15,754 | 1,11,615 |
⚖️ Peer Comparison — Chemicals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| PIDILITIND | 1.50 L Cr | 56.5 | 33.4% | — | 0.01 |
| SRF | 73,336 | 33.9 | 15.6% | — | 0.36 |
| LINDEINDIA | 54,023 | 98.9 | 17.5% | — | 0.00 |
| FLUOROCHEM | 48,430 | 79.2 | 9.6% | — | 0.34 |
| NAVINFLUOR | 42,306 | 53.5 | 22.2% | — | 0.31 |
| GODREJIND | 34,967 | 29.8 | 9.2% | — | 4.57 |
| HSCL | 34,188 | 42.5 | 20.7% | — | 0.16 |
| AETHER | 22,546 | 95.6 | 13.8% | — | 0.08 |
| DEEPAKNTR | 20,882 | 26.6 | 15.3% | — | 0.26 |
| CASTROLIND | 19,817 | 18.7 | 76.2% | — | 0.00 |
🔗 Peer Stock Analyses
📋 Recent Filings
- 🔴 Announcement2026-10-01Balaji Amines disclosed a January 10, 2025 warning letter from the Food & Drug Administration over an unauthorized pharmaceutical use of its technical…
- 🔴 Announcement2026-10-01Balaji Amines disclosed a regulatory intimation regarding a Foreign Trade Order dated August 13, 2024 that placed the company on a denied entity list.…
- 🔴 Announcement2026-09-28Balaji Amines announced the end of Mr. Rajendrakumar Mohanprasad Tapadiya's second term as Independent Director on the board of its material subsidiar…
- Announcement2026-09-28Balaji Amines Ltd announced that its trading window will close on October 1, 2026, and remain shut until 48 hours after the un-audited Q2 results are …
- 🔴 Announcement2026-09-24Balaji Amines announced commercial production of its expanded Acetonitrile plant at Solapur, effective September 24, 2026, boosting capacity to 1,440 …
- 🔴 Announcement2026-09-15Balaji Amines Limited announced the withdrawal of its credit rating on bank loan facilities by India Ratings and Research, effective September 15, 202…
- 🔴 Announcement2026-09-12Balaji Amines Ltd announced the withdrawal of its credit rating by India Ratings and Research (Ind-Ra) after the company cleared all bank loan exposur…
- Announcement2026-08-17Balaji Amines Limited announced a plant visit and investor meeting scheduled for August 25, 2026, in Solapur, Maharashtra, to discuss publicly availab…
- Announcement2026-08-13Balaji Amines Limited announced a virtual investor meeting hosted by Phillip Capital on August 21, 2026 at 4:00 PM IST, providing analysts and investo…
- 🟡 Board Meeting2026-07-27The Board of Balaji Amines approved unaudited standalone and consolidated financial results for Q1 FY2026, noting limited review reports from auditors…
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-10-01.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when BALAMINES files new disclosures
Track BALAMINES filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track BALAMINES — FreeFree account · 2 AI queries/day